Legal & General Group
ARRY

Legal & General Group’s Array Biopharma Inc ARRY Stock Holding History

Legal & General Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-119,925
Closed -$5.56M – 3502
2019
Q2 		$5.56M Buy
119,925
+5,982
+5% +$168K ﹤0.01% 1232
2019
Q1 		$2.78M Buy
113,943
+23,971
+27% +$499K ﹤0.01% 1538
2018
Q4 		$1.28M Buy
89,972
+14,340
+19% +$218K ﹤0.01% 1813
2018
Q3 		$1.15M Sell
75,632
-767
-1% -$11.8K ﹤0.01% 1911
2018
Q2 		$1.28M Sell
76,399
-4,286
-5% -$68.2K ﹤0.01% 1842
2018
Q1 		$1.32M Sell
80,685
-23,098
-22% -$370K ﹤0.01% 1797
2017
Q4 		$1.33M Buy
103,783
+22,205
+27% +$253K ﹤0.01% 1781
2017
Q3 		$1M Buy
81,578
+13,922
+21% +$129K ﹤0.01% 1864
2017
Q2 		$566K Buy
67,656
+11,546
+21% +$94.4K ﹤0.01% 2024
2017
Q1 		$500K Buy
56,110
+15,256
+37% +$162K ﹤0.01% 2032
2016
Q4 		$358K Buy
40,854
+17,643
+76% +$130K ﹤0.01% 2070
2016
Q3 		$146K Hold
23,211
– – ﹤0.01% 2114
2016
Q2 		$82K Hold
23,211
– – ﹤0.01% 2206
2016
Q1 		$70K Sell
23,211
-2,446
-10% -$7.33K ﹤0.01% 2259
2015
Q4 		$106K Hold
25,657
– – ﹤0.01% 2037
2015
Q3 		$120K Hold
25,657
– – ﹤0.01% 1935
2015
Q2 		$185K Hold
25,657
– – ﹤0.01% 1783
2015
Q1 		$192K Hold
25,657
– – ﹤0.01% 1699
2014
Q4 		$123K Hold
25,657
– – ﹤0.01% 1829
2014
Q3 		$96K Buy
+25,657
New +$101K ﹤0.01% 1910

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Legal & General Group's ARRY Position: Q3 2019 in Review

Legal & General Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 119,925 shares — an estimated $5.56M sold.

Legal & General Group first reported a position in ARRY in Q3 2014 and held it in 20 quarters. The position peaked at $5.56M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Legal & General Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Legal & General Group sold 119,925 Array Biopharma Inc shares in Q3 2019, an estimated $5.56M.
  • Legal & General Group first reported a position in Array Biopharma Inc in Q3 2014 and held it in 20 quarters.
  • Legal & General Group's Array Biopharma Inc position peaked at $5.56M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.